Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma (mSOX)
This study is currently recruiting participants.
Verified March 2012 by Sixth Affiliated Hospital, Sun Yat-sen University
Study NCT01552980   Information provided by Sixth Affiliated Hospital, Sun Yat-sen University

First Received on March 6, 2012.   Last Updated on March 27, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gastric Adenocarcinoma
Additional conditions recognized in this trial
Adenocarcinoma
Adenocarcinoma, Mucinous
Stomach Neoplasms
More general conditions related to this trial
Carcinoma
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Cystic, Mucinous, and Serous
Neoplasms, Glandular and Epithelial
Stomach Diseases
Interventions listed in this trial
S-1 and Oxaliplatin
Additional drug interventions recognized in this trial
Oxaliplatin
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Sixth Affiliated Hospital, Sun Yat-sen University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services